⌘K

Login Start Free

Home/Filings/4/0001855763-22-000018

4//SEC Filing

Downey Gregory 4

Accession 0001855763-22-000018

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 2:34 PM ET

Size

13.6 KB

Accession

0001855763-22-000018

Insider Transaction Report

Form 4

Period: 2022-10-14

Lexaria Bioscience Corp.LEXX

Chief Financial Officer

Transactions

Award
common shares
2022-10-14$2.09/sh+121$253→ 1,954 total

Holdings

Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
4,000
Stock Options
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)
17,000
common shares
1,833
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
8,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (11,000 underlying)
46,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
12,000
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (8,000 underlying)
25,000
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
35,000

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001855801

Filing Metadata

Form type: 4
Filed: Oct 17, 8:00 PM ET
Accepted: Oct 18, 2:34 PM ET
Size: 13.6 KB

View on SEC.gov